Insider Transactions in Q2 2024 at Mineralys Therapeutics, Inc. (MLYS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2024
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,940
-1.59%
|
$164,340
$11.73 P/Share
|
|
Jun 18
2024
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,607
-1.73%
|
$182,677
$11.99 P/Share
|
|
Jun 17
2024
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,766
-1.82%
|
$213,192
$12.25 P/Share
|
|
Jun 14
2024
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,229
-1.64%
|
$194,748
$12.52 P/Share
|
|
Jun 13
2024
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
39,961
-3.87%
|
$479,532
$12.74 P/Share
|
|
Jun 12
2024
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,607
-1.58%
|
$199,284
$12.77 P/Share
|
|
Jun 12
2024
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,349
+6.61%
|
$6,349
$1.08 P/Share
|
|
Jun 11
2024
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,017
+5.68%
|
$0
$0.54 P/Share
|
|
Jun 11
2024
|
Adam Scott Levy CFO and Secretary |
SELL
Open market or private sale
|
Direct |
96,815
-27.48%
|
$1,161,780
$12.94 P/Share
|
|
May 13
2024
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,366
+7.0%
|
$0
$0.81 P/Share
|
|
May 09
2024
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100
-0.15%
|
$1,500
$15.0 P/Share
|
|
May 09
2024
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.15%
|
$100
$1.08 P/Share
|
|
Apr 12
2024
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,349
+8.66%
|
$6,349
$1.08 P/Share
|
|
Apr 11
2024
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,017
+7.64%
|
$0
$0.54 P/Share
|